Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 18/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21477400 | 0.84 | AR (0.33) | CYP3A4 | |
| SCHEMBL19780755 | 0.81 | ALDH1A1 (0.49) | FASNCYP3A4 | |
| SCHEMBL6082932 | 0.79 | KDM4E (0.50) | CYP3A4 | |
| SCHEMBL21477411 | 0.77 | GSK3A (0.44) | CYP3A4 | |
| SCHEMBL22695635 | 0.73 | GSK3A (0.39) | CYP3A4 | |
| SCHEMBL21480942 | 0.73 | FASN (0.47) | FASN | |
| SCHEMBL19780650 | 0.73 | FASN (0.47) | FASN | |
| SCHEMBL29613268 | 0.72 | RAB9A (0.53) | CYP3A4 | |
| SCHEMBL9001847 | 0.72 | FASN (0.52) | FASN | |
| SCHEMBL13169226 | 0.72 | RAB9A (0.53) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322826-A1 | METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2023-10-12 | — | — | US | disclosed |
| US-11713332-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713332-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | FASN 3519/4885TMEM97 3898/4885HRH4 4734/4885 |
| US-20230322826-A1 | METAL COMPLEXES | AP1M1, SOD1, AP3M1 | FASN 3519/4885TMEM97 3898/4885HRH4 4734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.